NDC 42291-301-30 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42291-301
- Requested NDC
- 42291-301-30
- Package NDCs from labels
- 42291-301-50, 42291-301-30
- Manufacturer
- AvKARE
- Effective date
- 2022-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - AvKARE | AvKARE | 2022-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42291-301-10 | EA - Each | 42291-301 | 2148c67a-da4a-4fc6-9965-d2dc7283324f | 1 | 2013-02-13 |
| 42291-301-18 | EA - Each | 42291-301 | a94c3a5a-b7d2-4162-bcc7-69c42cf25512 | 1 | 2013-02-13 |
| 42291-301-27 | EA - Each | 42291-301 | a3157c8a-e4c6-4912-b9da-4665436ad940 | 1 | 2013-02-13 |
| 42291-301-30 | EA - Each | 42291-301 | 4b3388ae-99e2-4ac5-a747-7f90798c60a8 | 1 | 2013-02-13 |
| 42291-301-50 | EA - Each | 42291-301 | 5f4b3f45-a21d-4e20-a2e3-3296ff0a4325 | 1 | 2018-10-11 |
| 42291-301-90 | EA - Each | 42291-301 | 7169cf0d-6ae5-416d-81f2-8160bb398680 | 1 | 2013-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | JVET PHARMACEUTICALS LLC | 63a5fc6d-ca57-4726-b70d-805ac023d959 | 2025-12-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Glenmark Pharmaceuticals Inc., USA | 3865a6e3-112c-490c-82ac-35401336b16e | 2025-12-05 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Precision Dose, Inc. | 021329d0-7d32-4fd8-81bf-a8b0d8b49e43 | 2025-12-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Redpharm Drug | 44f2b497-55b2-864f-e063-6294a90ad6d5 | 2025-12-02 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Kesin Pharma Corporation | 4470a567-93a6-a293-e063-6394a90affc1 | 2025-11-25 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | b74a427c-9cc1-4b15-9ed2-cc891741fe67 | 2025-11-19 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Acella Pharmaceuticals, LLC | 3255245c-6ae6-46ab-a1c1-0b8d4d4cdaa2 | 2025-11-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 5134369d-c7f6-4569-a425-d50e5a5d694f | 2025-10-29 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Mullan Pharmaceutical Inc. | 47a22de2-ec66-45be-8648-89ed3ab6e67e | 2025-10-28 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 25befbfa-5125-4363-8306-f862e81c0a6f | 2025-10-28 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d9d78138-e1e9-4107-9099-4910cb1422d8 | 2025-10-22 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 6e900fc4-a2b3-411f-9ab7-8dcbb97b697b | 2025-10-16 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | aa246838-609c-4254-a8ec-d6f463a17960 | 2025-10-16 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | efb86e22-5a84-4b33-aad0-71dd5a2c6c8f | 2025-10-13 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 1ead7343-ab25-41b5-af4f-f903470e1dd9 | 2025-10-10 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 781b0d62-a760-4371-8908-1f61329928a6 | 2025-10-10 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | STALLION LABORATORIES PRIVATE LIMITED | b26fd0c6-6aab-4957-8a32-cc7adb9b5fc9 | 2025-10-03 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | American Health Packaging | bbfdedd7-2baf-4bc6-be59-548a5cf21752 | 2025-10-03 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | be9a572d-e98a-41c1-83c5-859d9176dd1c | 2025-10-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | eaf5e41e-8ed3-404e-84e0-392bebdbc0b7 | 2025-10-03 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.